Cargando…

Evaluation of the Cost of a High-Dose Intravenous Iron Protocol in a Regional Hemodialysis Program: Research Letter

BACKGROUND: Intravenous (IV) iron and erythropoietin stimulating agents (ESAs) are standard treatments for anemia in patients receiving maintenance hemodialysis. These medications are associated with significant costs to hemodialysis programs and patients. Recent trial evidence demonstrated that a h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papini, Adam, Manns, Braden J., Elliott, Meghan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Clinical Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851128/ https://www.ncbi.nlm.nih.gov/pubmed/35186304 http://dx.doi.org/10.1177/20543581211063984

Ejemplares similares

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
por: Peters, N. O., et al.
Publicado: (2017)

Options for intravenous iron supplementation in hemodialysis patients
por: Kong, Ji Yoon, et al.
Publicado: (2020)

Activated protein C: cost-effective or costly?
por: Brar, Savtaj Singh, et al.
Publicado: (2007)

The impact of nocturnal hemodialysis on sexual function
por: Bass, Adam, et al.
Publicado: (2012)

A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol
por: Johnson, Jeffrey A., et al.
Publicado: (2020)

Protocol for a pilot randomised controlled trial of an educational programme for adults on chronic haemodialysis with fatigue (Fatigue-HD)
por: Farragher, Janine F, et al.
Publicado: (2019)

Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial)
por: Anumas, Suthiya, et al.
Publicado: (2023)

Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial
por: Susantitaphong, Paweena, et al.
Publicado: (2020)

The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: Rationale and study design of a randomized controlled pilot study
por: Walsh, Michael, et al.
Publicado: (2006)

“You need a team”: perspectives on interdisciplinary symptom management using patient-reported outcome measures in hemodialysis care—a qualitative study
por: Baragar, Brigitte, et al.
Publicado: (2023)

High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
por: Honda, Hirokazu, et al.
Publicado: (2017)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
por: Kanshaiym, Sakiyeva, et al.
Publicado: (2020)

Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015)

Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013)

Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
Publicado: (2017)

Low-Dose Maintenance Intravenous Iron Therapy Can Prevent Anemia in Children with End-Stage Renal Disease Undergoing Chronic Hemodialysis
por: Ambarsari, Cahyani Gita, et al.
Publicado: (2020)

Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients
por: Kshirsagar, Abhijit V., et al.
Publicado: (2013)

Alignment Among Patient, Caregiver, and Health Care Provider Perspectives on Hemodialysis Vascular Access Decision-Making: A Qualitative Study
por: Schneider, Angela R., et al.
Publicado: (2023)

High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial
por: Macher, Susanne, et al.
Publicado: (2016)

Trace elements in hemodialysis patients: a systematic review and meta-analysis
por: Tonelli, Marcello, et al.
Publicado: (2009)

Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
por: Diebold, Matthias, et al.
Publicado: (2019)

High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis
por: Petrie, Mark C, et al.
Publicado: (2021)

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study
por: Thompson, Stephanie, et al.
Publicado: (2017)

Economic Analysis of Intravenous Iron in Patients with Iron Deficiency Anemia Due to Inflammatory Bowel Disease: Considerations for Clinicians [Letter]
por: Pollock, Richard F, et al.
Publicado: (2022)

Patient-reported outcome measures in the care of in-centre hemodialysis patients
por: Davison, Sara N., et al.
Publicado: (2021)

Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial
por: Woodland, Andrea L., et al.
Publicado: (2017)

The dynamic nature of patient engagement within a Canadian patient‐oriented kidney health research network: Perspectives of researchers and patient partners
por: Elliott, Meghan J., et al.
Publicado: (2023)

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
por: Schaefer, Benedikt, et al.
Publicado: (2016)

Correction to: Patient-reported outcome measures in the care of in-centre hemodialysis patients
por: Davison, Sara N., et al.
Publicado: (2021)

Role of single-dose intravenous iron therapy for the treatment of anaemia after orthopaedic trauma: protocol for a pilot randomised controlled trial
por: Peterson, Danielle F, et al.
Publicado: (2023)

Protocol for a parallel economic evaluation of a trial comparing two surgical strategies in severe complicated intra-abdominal sepsis: the COOL-cost study
por: Ng-Kamstra, Joshua S., et al.
Publicado: (2020)

Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial
por: Laso-Morales, María Jesús, et al.
Publicado: (2019)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
por: Basha, Ahmad, et al.
Publicado: (2021)

Trace element supplementation in hemodialysis patients: a randomized controlled trial
por: Tonelli, Marcello, et al.
Publicado: (2015)

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
por: Riccio, Eleonora, et al.
Publicado: (2020)

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study
por: Louzada, Martha L., et al.
Publicado: (2016)

Testing equivalence of two doses of intravenous iron to treat iron deficiency in pregnancy: A randomised controlled trial
por: Froessler, Bernd, et al.
Publicado: (2022)

Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study
por: Deng, Yinghui, et al.
Publicado: (2017)

Ferrous iron content of intravenous iron formulations
por: Gupta, Ajay, et al.
Publicado: (2016)

Intravenous Iron Therapy with Saccharated Iron Oxide
por: Deshmukh, P. L.
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_opvorcavqtqsrag5p9ibkar1oc